Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtrer
Plus de filtres











Gamme d'année
1.
Braz J Med Biol Res ; 51(9): e7552, 2018 Jul 02.
Article de Anglais | MEDLINE | ID: mdl-29972429

RÉSUMÉ

Guarana (Paullinia cupana) is habitually ingested by people in the Amazon region and is a key ingredient in various energy drinks consumed worldwide. Extension in longevity and low prevalence of chronic age-related diseases have been associated to habitual intake of guarana. Anti-aging potential of guarana was also demonstrated in Caenorhabditis elegans; however, the mechanisms involved in its effects are not clear. Herein, we investigated the putative pathways that regulate the effects of guarana ethanolic extract (GEE) on lifespan using C. elegans. The major known longevity pathways were analyzed through mutant worms and RT-qPCR assay (DAF-2, DAF-16, SKN-1, SIR-2.1, HSF-1). The possible involvement of purinergic signaling was also investigated. This study demonstrated that GEE acts through antioxidant activity, DAF-16, HSF-1, and SKN-1 pathways, and human adenosine receptor ortholog (ADOR-1) to extend lifespan. GEE also downregulated skn-1, daf-16, sir-2.1 and hsp-16.2 in 9-day-old C. elegans, which might reflect less need to activate these protective genes due to direct antioxidant effects. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and also suggest purinergic signaling as a plausible therapeutic target for longevity studies.


Sujet(s)
Antioxydants/pharmacologie , Caenorhabditis elegans/effets des médicaments et des substances chimiques , Paullinia/composition chimique , Extraits de plantes/pharmacologie , Vieillissement/effets des médicaments et des substances chimiques , Animaux , Antioxydants/isolement et purification , Caenorhabditis elegans/physiologie , Longévité/effets des médicaments et des substances chimiques , RT-PCR , Facteurs temps
2.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;51(9): e7552, 2018. tab, graf
Article de Anglais | LILACS | ID: biblio-951753

RÉSUMÉ

Guarana (Paullinia cupana) is habitually ingested by people in the Amazon region and is a key ingredient in various energy drinks consumed worldwide. Extension in longevity and low prevalence of chronic age-related diseases have been associated to habitual intake of guarana. Anti-aging potential of guarana was also demonstrated in Caenorhabditis elegans; however, the mechanisms involved in its effects are not clear. Herein, we investigated the putative pathways that regulate the effects of guarana ethanolic extract (GEE) on lifespan using C. elegans. The major known longevity pathways were analyzed through mutant worms and RT-qPCR assay (DAF-2, DAF-16, SKN-1, SIR-2.1, HSF-1). The possible involvement of purinergic signaling was also investigated. This study demonstrated that GEE acts through antioxidant activity, DAF-16, HSF-1, and SKN-1 pathways, and human adenosine receptor ortholog (ADOR-1) to extend lifespan. GEE also downregulated skn-1, daf-16, sir-2.1 and hsp-16.2 in 9-day-old C. elegans, which might reflect less need to activate these protective genes due to direct antioxidant effects. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and also suggest purinergic signaling as a plausible therapeutic target for longevity studies.


Sujet(s)
Animaux , Extraits de plantes/pharmacologie , Caenorhabditis elegans/effets des médicaments et des substances chimiques , Paullinia/composition chimique , Antioxydants/pharmacologie , Facteurs temps , Vieillissement/effets des médicaments et des substances chimiques , Caenorhabditis elegans/physiologie , RT-PCR , Longévité/effets des médicaments et des substances chimiques , Antioxydants/isolement et purification
3.
Exp Clin Endocrinol Diabetes ; 125(5): 335-341, 2017 May.
Article de Anglais | MEDLINE | ID: mdl-28561194

RÉSUMÉ

The aim of the study was to investigate the association between Glutathione S-transferase P1 (GSTP1) gene polymorphism with obesity and markers of cardiometabolic risk. A cross-sectional study was carried out in individuals aged≥18 and ≤30 years. The study included 54 normal weight, 27 overweight and 68 obese volunteers. Anthropometric measurements and biochemical parameters were evaluated, the DNA was extracted from blood samples and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to measure GSTP1 Ile105Val gene polymorphism of the study participants. Also, biochemical analysis and hormone assays were carried out. A positive association between GSTP1 polymorphism and obesity was observed on subjects carrying at least one G allele (AG and GG). GG genotype was found only in the obese group. The G allele carriers presented 2.4 times higher chance of obesity when compared to those with the AA genotype. These results were independent of sex and age. We suggest that despite a study in population regional (south of Brazil), the GSTP1 gene polymorphism may play a significant role in the increase of susceptibility of obesity and contribute to identify the cardiovascular risk in young adults.


Sujet(s)
Allèles , Prédisposition génétique à une maladie , Glutathione S-transferase pi/génétique , Mutation faux-sens , Obésité/génétique , Polymorphisme de restriction , Adulte , Substitution d'acide aminé , Femelle , Humains , Mâle , Obésité/enzymologie , Jeune adulte
4.
Zygote ; 25(2): 111-119, 2017 Apr.
Article de Anglais | MEDLINE | ID: mdl-28264730

RÉSUMÉ

Previous investigations suggested that elevated cell-free DNA (cfDNA) can indicate non-healthy states. However, the potential association between cfDNA seminal plasma levels and fertility sperm parameters has not yet been determined. Therefore, the present study evaluated the association between seminal cfDNA levels and sperm fertility criteria to determine the use of seminal cfDNA quantification. An in vivo protocol quantified cfDNA levels of semen samples obtained from 163 male patients using fluorescent PicoGreen dye staining. To confirm if semen cfDNA quantification is realistic, an in vitro complementary test was performed using three or four semen samples. The fresh sperm samples were exposed to paraquat that generates high levels of superoxide anion causing oxidative stress and cell mortality. The results showed significant association between dsDNA levels and several sperm fertility parameters, such as low viability and alterations of motility and morphology. The in vitro analysis confirmed the association between dsDNA levels and sperm viability. Together, these results suggest that dsDNA levels could be an important biomarker to test sperm fertility.


Sujet(s)
ADN/analyse , Colorants fluorescents/composition chimique , Infertilité masculine/physiopathologie , Analyse du sperme/méthodes , Sperme/composition chimique , Mobilité des spermatozoïdes , Adulte , Système acellulaire , Humains , Mâle , Composés chimiques organiques/composition chimique , Stress oxydatif
5.
Pharmacogenomics J ; 16(6): 501-506, 2016 11.
Article de Anglais | MEDLINE | ID: mdl-26882122

RÉSUMÉ

Rosuvastatin is a cholesterol-lowering drug that also attenuates the inflammatory process and oxidative stress via the reduction of superoxide anion production. Superoxide anions are metabolized by manganese-dependent superoxide dismutase (MnSOD or SOD2) in the mitochondria. In humans, there is a gene polymorphism where a change of alanine (Ala) to valine (Val) occurs at the 16th amino acid (Ala16Val-SOD2). The VV genotype has been associated with the risk of developing several metabolic diseases, such as hypercholesterolemia. Thus, to further explore this phenomenon, this study investigated the influence of the Val16Ala-SOD2 polymorphism on the lipid profile and inflammatory and fibrinolytic biomarkers of 122 hypercholesterolemic patients undergoing the first pharmacological cholesterol-lowering therapy who were treated with 20 mg rosuvastatin for 120 days. The findings indicate that the VV patients who present a low-efficiency SOD2 enzyme exhibit an attenuated response to rosuvastatin compared with the A-allele patients. The effect of rosuvastatin on inflammatory and fibrinolytic biomarkers was also less intense in the VV patients. These results suggest some pharmacogenetic effects of Val16Ala-SOD2 in hypercholesterolemia treatment.


Sujet(s)
Anti-inflammatoires/usage thérapeutique , Antioxydants/usage thérapeutique , Fibrinolyse/effets des médicaments et des substances chimiques , Fibrinolytiques/usage thérapeutique , Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique , Hypercholestérolémie/traitement médicamenteux , Stress oxydatif/effets des médicaments et des substances chimiques , Variants pharmacogénomiques , Polymorphisme de nucléotide simple , Rosuvastatine de calcium/usage thérapeutique , Superoxide dismutase/génétique , Adulte , Sujet âgé , Marqueurs biologiques/sang , Cholestérol/sang , Résistance aux substances/génétique , Femelle , Fréquence d'allèle , Hétérozygote , Homozygote , Humains , Hypercholestérolémie/sang , Hypercholestérolémie/enzymologie , Hypercholestérolémie/génétique , Médiateurs de l'inflammation/sang , Modèles logistiques , Mâle , Adulte d'âge moyen , Analyse multifactorielle , Pharmacogénétique , Phénotype , Études prospectives , Facteurs de risque , Superoxydes/métabolisme , Facteurs temps , Résultat thérapeutique , Jeune adulte
6.
Int Endod J ; 49(8): 737-45, 2016 Aug.
Article de Anglais | MEDLINE | ID: mdl-26174479

RÉSUMÉ

AIM: To evaluate the cytotoxicity, oxidative stress and genotoxicity in vitro of four iodoform pastes and three calcium hydroxide pastes. METHODOLOGY: Peripheral blood mononuclear cells (PBMCs) and pure calf thymus DNA (dsDNA) were exposed to extracts of the pastes. Cytotoxicity was assessed with the MTT assay. Generation of reactive oxygen species (ROS) was evaluated using a DCFH-DA assay, and lipid peroxidation was evaluated using a TBARS assay. Genotoxicity was evaluated using the alkaline comet assay and Genomodifier capacity assay (GEMO). All tests were performed after 24 h and 72 h of cell exposure, except GEMO. After performing the Kolmogorov-Smirnov test, data were analysed by Kruskal-Wallis and Dunn's post-tests, and anova with Dunnett's post-test, with a significance level established at P < 0.05. RESULTS: The MTT assay revealed that chlorhexidine, Maxitrol and neomycin sulphate + bacitracin pastes decreased cell viability after 24 h (P < 0.05). No group was associated with a significant decreased cell viability or lipid peroxidation after 72 h. Calcium hydroxide pastes increased the cell viability levels at both experimental times (P < 0.05). Lipid peroxidation was observed with the exposure of cells to calcium hydroxide pastes after 24 h (P < 0.05). Exposure to chlorhexidine, Guedes-Pinto and calcium hydroxide pastes resulted in a significant increase in ROS after 24 h (P < 0.05), whereas iodoform pastes and Calen thickened with zinc oxide significantly increased the ROS after 72 h (P < 0.05). The comet assay revealed that exposure of the PBMCs to iodoform pastes did not damage DNA at either period of time (P > 0.05). However, chlorhexidine paste caused DNA damage in dsDNA (P < 0.05). Calcium hydroxide pastes caused DNA damage in both tests (P < 0.05). CONCLUSION: The pastes varied in their ability to induce cytotoxicity, genotoxicity and oxidative stress. In general, Guedes-Pinto, Maxitrol and neomycin sulphate + bacitracin pastes exhibited better biocompatibility in vitro.


Sujet(s)
ADN/effets des médicaments et des substances chimiques , Hydrocarbures iodés/pharmacologie , Agranulocytes/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Produits d'obturation des canaux radiculaires/pharmacologie , Analyse de variance , Animaux , Bovins , Altération de l'ADN , Humains , Agranulocytes/métabolisme , Test de matériaux , Espèces réactives de l'oxygène/métabolisme , Statistique non paramétrique , Dent de lait , Tests de toxicité
7.
Phytother Res ; 30(1): 49-57, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-26514663

RÉSUMÉ

Hypercholesterolemia is a metabolic disorder characterized by high levels of low-density lipoprotein and blood cholesterol, causing inflammatory lesion. Purinergic signaling modulates the inflammatory and immune responses through adenine nucleotides and nucleoside. Guaraná has hypocholesterolemic and antiinflammatory properties. Considering that there are few studies demonstrating the effects of guaraná powder on the metabolism of adenine nucleotides, we investigated its effects on the activity of ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase) and ecto-adenosine deaminase activity in lymphocytes of rats with diet-induced hypercholesterolemia. The rats were divided into hypercholesterolemic and normal diet groups. Each group was subdivided by treatment: saline, guaraná powder 12.5, 25, or 50 mg/kg/day and caffeine concentration equivalent to highest dose of guaraná, fed orally for 30 days. An increase in adenosine triphosphate hydrolysis was observed in the lymphocytes of rats with hypercholesterolemia and treated with 25 or 50 mg/kg/day when compared with the other groups. The hypercholesterolemic group treated with the highest concentration of guaraná powder showed decreased ecto-adenosine deaminase activity compared with the normal diet groups. Guaraná was able to reduce the total cholesterol and low-density lipoprotein cholesterol to basal levels in hypercholesterolemic rats. High concentrations of guaraná associated with a hypercholesterolemic diet are likely to have contributed to the reduction of the inflammatory process.


Sujet(s)
Caféine/pharmacologie , Hypercholestérolémie/traitement médicamenteux , Paullinia/composition chimique , Théobromine/pharmacologie , Théophylline/pharmacologie , Adenosine deaminase/métabolisme , Animaux , Cholestérol/sang , Cholestérol LDL/sang , Alimentation riche en graisse , Lymphocytes/enzymologie , Mâle , Préparations à base de plantes/pharmacologie , Rats , Rat Wistar
8.
Free Radic Res ; 49(2): 204-9, 2015 Feb.
Article de Anglais | MEDLINE | ID: mdl-25496432

RÉSUMÉ

Proteins are important targets of several modifications caused by oxidative stress, leading to structural changes and consequently partial or total loss of their functions. The oxidized proteins include advanced oxidation protein products (AOPP) derived from oxidation-modified albumin, as well as fibrinogen and lipoproteins. An increase in AOPP levels indicates an oxidative stress state and the presence of coexisting inflammation. Several investigations have also suggested an association between high AOPP levels and aging-related diseases. However, the link between elevated AOPP levels and elderly mortality risk has not yet been investigated. Here, we report on a 5-year longitudinal study that investigated the potential association between AOPP levels and mortality using a population-based representative sample of riparian elders living in Brazilian Amazon region (Maués-AM). Age, sex, socioeconomic and cultural conditions, chronic morbidities, polypharmacy, and previous morbidities were also tested as potential confounders. The AOPP levels were measured in 540 (84.78%) individuals, all of whom were followed over a 5-year period in order to establish the mortality rate. Within this study period, 74 (13.7%) elders died and 466 (86.3%) survived. The AOPP levels were higher among the elders who died within the 5-year period (46.27 ± 40.6 mmol/L) compared with those who survived (36.79 ± 20.84 mmol/L) (p = 0.002). The analysis confirmed the link between high AOPP levels and mortality risk, independent of other intervenient factors. These results suggest that elevated AOPP levels could be used to predict mortality risk in elderly patients.


Sujet(s)
Produits d'oxydation avancée des protéines/sang , Vieillissement , Mortalité , Stress oxydatif , Sujet âgé , Sujet âgé de 80 ans ou plus , Marqueurs biologiques , Brésil , Femelle , Humains , Études longitudinales , Mâle , Adulte d'âge moyen , Risque
9.
Genet Mol Res ; 12(4): 5134-44, 2013 Oct 29.
Article de Anglais | MEDLINE | ID: mdl-24301773

RÉSUMÉ

Environmental contamination by methylmercury (MeHg) is an enormous public health problem in world regions such as Amazonia. MeHg toxic effects seem to be influenced by environmental and genetic factors. However, few studies have evaluated the genetic influences of MeHg toxicity in humans. Therefore, the aim of this study was to evaluate the genetic influence of Ala16Val manganese superoxide dismutase gene polymorphism (Ala16Val-MnSOD) on the cytotoxic effects of in vitro human leukocytes exposed to MeHg. Subjects were selected from 100 individuals aged 26.4 ± 7.3 years genotyped to Ala16Val-MnSOD polymorphism (AA = 6, VV = 6, and AV = 12) to perform in vitro testing using white blood cells (WBCs). Reactive oxygen species production was measured using 2',7'-dichlorofluorescein diacetate fluorimetric assay, and cell viability was measured using MTT assay on WBC samples from the same subjects that were both exposed and not exposed to MeHg (2.5 µM for 6 h). The results showed that AA- and VV-WBCs exposed to MeHg did not display increased reactive oxygen species levels compared to those in cells that were not exposed. However, AV-leukocytes exposed to MeHg displayed increased ROS levels. Cellular viability comparison among genotypes exposed to MeHg showed that the viability of AA-WBCs was lower than that of VV-WBC, with mean values of 3.46 ± 0.13 and 3.08 ± 0.77 (standard error), respectively (P = 0.033), whereas heterozygous cells (AV) displayed intermediate values. This difference was likely due to the higher basal H2O2 production of AA-WBCs compared to that of other genotypes. These results suggest that the Ala16Val-MnSOD polymorphism has toxicogenetic effects in human cells exposed to MeHg.


Sujet(s)
Leucocytes/effets des médicaments et des substances chimiques , Leucocytes/métabolisme , Composés méthylés du mercure/pharmacologie , Polymorphisme génétique , Superoxide dismutase/génétique , Allèles , Substitution d'acide aminé , Survie cellulaire/effets des médicaments et des substances chimiques , Fréquence d'allèle , Génotype , Humains , Espèces réactives de l'oxygène
10.
Am J Med Genet B Neuropsychiatr Genet ; 128B(1): 90-3, 2004 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-15211639

RÉSUMÉ

Smoking behavior is influenced by genetic factors. Polymorphisms affecting the dopaminergic system have been linked to smoking habits. The aim of this study was to investigate if the T102C polymorphism of the 5-HT(2A) receptor gene is related to tobacco use, since this receptor modulates the mesolimbic dopamine system and the C allele is associated with reduced receptor gene expression. A sample of 625 subjects were genotyped and classified according to their smoking behavior (never, former, or current smokers). We found differences in the distribution of the genotypes when the current smokers were compared with the never + former smokers, suggesting that T102C polymorphism is associated with maintenance, but not with initiation of the smoking habit. The CC genotype was more frequent in the current smokers than in the never + former smokers (chi(2) = 6.825, P = 0.03). The odds ratio of being a current smoker with a CC genotype was 1.63, 95% CI 1.06-2.51.


Sujet(s)
Polymorphisme génétique , Récepteur de la sérotonine de type 5-HT2A/génétique , Trouble lié au tabagisme/génétique , Adulte , Sujet âgé , Femelle , Fréquence d'allèle , Prédisposition génétique à une maladie , Génotype , Humains , Mâle , Adulte d'âge moyen , Épidémiologie moléculaire , Odds ratio , Polymorphisme de nucléotide simple , Trouble lié au tabagisme/épidémiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE